K

W

Wellington Management

Crunchbase
Pitchbook
Crunchbase

Deals on record

21

Common Fundraising Type

Equity

A
Atsena Therapeutics

Gene therapy • Clinical-stage

Wellington Management logo
Sofinnova Investments logo
Osage University Partners logo
Manning Family Foundation logo

Atsena Therapeutics is a clinical-stage gene therapy company focused on developing treatments for inherited retinal diseases such as X-linked retinoschisis and Leber congenital amaurosis type 1.

Series C
$150M
04/04/2025
Article
L
Lumafield

Industrial X-ray CT • Product development

Wellington Management logo
Spark Capital logo
Matter Venture Partners logo
Lux Capital logo

Lumafield provides industrial X-ray CT technology solutions to enhance product development and manufacturing processes.

Series C
$75M
03/14/2025
Article
H
Helicore Biopharma

Biopharma • Obesity Treatment

Versant Ventures logo
Wellington Management logo
OrbiMed logo
Longitude Capital logo

Helicore Biopharma develops glucose-dependent insulinotropic peptide (GIP) antagonist therapies for obesity treatment.

Series A
$65M
02/13/2025
Article
T
Tabby

Buy now pay later platform • Middle East operations

Wellington Management logo
STV logo
Hassana Investment Company logo
Blue Pool Capital logo

Tabby is a buy now, pay later platform that has raised $200 million in a Series D funding round, with plans to expand its product offerings and potentially prepare for an IPO.

Series E
$160M
02/12/2025
Article
P
PHȲND

Cloud gaming • Big-screen gaming

Wellington Management logo
Connecticut Innovations Fund logo
Bessemer Venture Partners logo

PHȲND provides a subscription-free cloud gaming platform that connects brand marketers with a big-screen gaming audience through non-intrusive ads and sponsorships.

Seed
$10M
02/11/2025
Article
A
Archer Aviation

VTOL • Aircraft

Wellington logo
Blackrock logo

Archer Aviation develops hybrid VTOL aircraft for defense applications, leveraging rapid aircraft development and AI systems integration.

Equity
$300M
02/11/2025
Article
S
Saluda Medical

Medical device • Neuromodulation

Wellington Management logo
TPG Life Sciences Innovation logo
T. Rowe Price Associates logo
Redmile Group logo

Saluda Medical develops and commercializes the Evoke® System, a closed-loop spinal cord stimulation device for managing chronic pain.

Equity
$100M
01/10/2025
Article
S
SiteOne Therapeutics

Biopharmaceutical • Ion Channel Modulators

Novo Holdings logo
OrbiMed logo
Mission BioCapital logo
Wellington Management logo

SiteOne Therapeutics is a biopharmaceutical company developing selective, small molecule ion channel modulators for treating sensory hyperexcitability disorders like pain and chronic cough.

Series C
$100M
12/18/2024
Article
C
Current

Consumer fintech • Banking platform

Wellington Management logo
General Catalyst logo
Cross River logo
Andreessen Horowitz logo

Current is a consumer fintech banking platform that offers accessible financial solutions, including faster paycheck access and secured credit-building cards.

Equity
$200M
12/13/2024
Article
A
Archer

VTOL • Aircraft

Wellington Management logo
United logo
Stellantis logo
2PointZero logo

Archer Aviation develops hybrid VTOL aircraft for defense applications, leveraging rapid aircraft development and AI systems integration.

Equity
$430M
12/12/2024
Article
n
nChroma Bio

Epigenetic editing • Genetic medicines

Wilson Sonsini Goodrich & Rosati logo
Wellington Management logo
T. Rowe Price logo
Sofinnova Partners logo

nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.

Equity
$75M
12/11/2024
Article
A
Amp Robotics

AI-driven • Robotic systems

Amp Robotics provides AI-driven robotic systems for waste sorting on an "as a service" model, charging per ton of waste sorted.

Series D
$91M
12/05/2024
Article
A
AMP

ECommerce • Software Ecosystem

AMP is a Sydney-based eCommerce platform that provides an interconnected, end-to-end solution for eCommerce merchants, aiming to consolidate multiple apps into one manageable system.

Series D
$91M
12/05/2024
Article
B
Beta Bionics

Medical Technology • Diabetes Management

Wellington Management logo
RTW Investments logo
Soleus Capital logo
Sands Capital logo

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.

Series E
$60M
11/15/2024
Article
M
Metsera

Biopharmaceutical • Clinical-stage

Venrock logo
Wellington Management logo
T. Rowe Price logo
SymBiosis logo

Metsera is a clinical-stage biopharmaceutical company developing next-generation treatments for obesity and metabolic diseases using their innovative platforms and Nutrient-Stimulated Hormone analog peptides.

Series B
$215M
11/13/2024
Article
C
Crisp

Collaborative Commerce • AI

Prologis logo
Wellington Management logo
Toshiba logo
Socium Ventures logo

Crisp provides an AI-driven Collaborative Commerce platform that optimizes supply chains, reduces waste, and improves profitability for consumer packaged goods (CPG) brands.

Series B
$72M
09/25/2024
Article
T
Trace Machina

Simulation • Testing

Wellington Management logo
Verissimo Ventures logo
Sequoia Capital logo
Samsung Next logo

Trace Machina develops a simulation testing platform called NativeLink to test and validate software for autonomous systems like self-driving cars and robotics.

Seed
$4.7M
08/22/2024
Article
M
Mindset Care

AI-driven solutions • Social Security Disability benefits

Wellington Management logo
XYZ logo
Tubbs Ventures logo
Science Inc. logo

Mindset Care simplifies Social Security Disability benefits applications for individuals with serious mental illnesses using AI-driven solutions and experienced disability attorneys.

Equity
$13M
08/20/2024
Article
T
Tabby

Buy now pay later platform • Middle East operations

STV logo
Sequoia Capital India logo
PayPal Ventures logo
Mubadala Investment Capital logo

Tabby is a buy now, pay later platform that has raised $200 million in a Series D funding round, with plans to expand its product offerings and potentially prepare for an IPO.

Series D
$200M
11/01/2023
Article
A
Avalyn Pharma

Biopharmaceutical • Respiratory Diseases

Perceptive Xontogeny Venture Funds logo
Wellington Management logo
Vida Ventures logo
T. Rowe Price Associates logo

Avalyn Pharma is a biopharmaceutical company that develops inhalation therapies for rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases, with a focus on creating new inhaled formulations of approved medicines.

Series C
$175M
09/27/2023
Article
F
FORE Biotherapeutics

Precision Oncology • Clinical Development

SR One logo
Medicxi logo
Wellington Management logo
Samsung Securities logo

FORE Biotherapeutics is a precision oncology company that focuses on the clinical development of plixorafenib, a novel small-molecule inhibitor for treating BRAF-altered tumors.

Series D
$75M
08/23/2023
Article